9.33MMarket Cap-625P/E (TTM)
0.2535High0.1900Low6.78MVolume0.1900Open0.1963Pre Close1.51MTurnover25.85%Turnover RatioLossP/E (Static)46.66MShares1.205052wk High-1.06P/B5.24MFloat Cap0.111252wk Low--Dividend TTM26.22MShs Float7.3500Historical High--Div YieldTTM32.35%Amplitude0.1112Historical Low0.2230Avg Price1Lot Size
NLS Pharmaceutics Stock Forum
NLS Pharmaceutics Ltd. (NASDAQ: NLSP)(NASDAQ: NLSPW), a Swiss clinical-stage biopharmaceutical company focused on developing therapies for rare and complex central nervous system disorders, has announced preclinical results from multiple in vitro studies targeting the alpha-synuclein protein (α-synuclein), particular...
NLSP is -13.4% to $0.21.
The company said it has entered into a definitive agreement for the issuance and sale of 3.28 million common shares at $0.24 per share.
No comment yet